Clinton S. George
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Clinton S. George has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
David J. Chaplin
Oxigene Inc., 701 Gateway Boulevard, Suite 210, South San Francisco, California 94080, United States
2 shared publicationsJustin K. Tidmore
Department of Chemistry and Biochemistry, Baylor University, One Bear Place #97348, Waco, Texas 76798-7348, United States
2 shared publications- Kevin G. Pinney
Department of Chemistry and Biochemistry, Baylor University, One Bear Place #97348, Waco, TX 76798-7348, USA
2 shared publications Madhavi Sriram
Department of Chemistry and Biochemistry, Baylor University, One Bear Place #97348, Waco, Texas 76798-7348, United States
2 shared publicationsMary Lynn Trawick
Department of Chemistry and Biochemistry, Baylor University, One Bear Place #97348, Waco, Texas 76798-7348, United States
2 shared publicationsRajendra P. Tanpure
Department of Chemistry and Biochemistry, Baylor University, One Bear Place #97348, Waco, TX 76798-7348, United States
2 shared publications
Latest Publications
- 1 December 2013
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 21 (24) , 8019-8032
Synthesis of structurally diverse benzosuberene analogues and their biological evaluation as anti-cancer agents
- 1 December 2013
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 21 (24) , 8019-8032
Synthesis of structurally diverse benzosuberene analogues and their biological evaluation as anti-cancer agents
- 21 March 2012
- Published by Royal Society of Chemistry (RSC) in MedChemComm
- Vol. 3 (6) , 720-724
An amino-benzosuberene analogue that inhibits tubulin assembly and demonstrates remarkable cytotoxicity
The recent discovery of a small-molecule benzosuberene-based phenol that demonstrates remarkable picomolar cytotoxicity against selected human cancer cell lines and strongly inhibits tubulin polymerization (1–2 μM) inspired the design and synthesis of a variety of new, structurally diverse benzosuberene derivatives. An efficient synthetic route to functionalized benzosuberenes was developed. This methodology utilized a Wittig reaction, followed by a selective alkene reduction and ring-closing cyclization to form the core benzosuberone structure. This synthetic route facilitated the preparation of a 4-nitro-1-(3′,4′,5′-trimethoxyphenyl) benzosuberene derivative and its corresponding 4-amino analogue in good yield. The 4-amino analogue was a strong inhibitor of tubulin polymerization (1.2 μM), demonstrated enhanced cytotoxicity against the human cancer cell lines examined (GI50 = 33 pM against SK-OV-3 ovarian cancer, for example), and exhibited a concentration dependent disruption of a pre-established capillary-like network of tubules formed from human umbilical vein endothelial cells.
- 21 March 2012
- Published by Royal Society of Chemistry (RSC) in MedChemComm
- Vol. 3 (6) , 720-724
An amino-benzosuberene analogue that inhibits tubulin assembly and demonstrates remarkable cytotoxicity
The recent discovery of a small-molecule benzosuberene-based phenol that demonstrates remarkable picomolar cytotoxicity against selected human cancer cell lines and strongly inhibits tubulin polymerization (1–2 μM) inspired the design and synthesis of a variety of new, structurally diverse benzosuberene derivatives. An efficient synthetic route to functionalized benzosuberenes was developed. This methodology utilized a Wittig reaction, followed by a selective alkene reduction and ring-closing cyclization to form the core benzosuberone structure. This synthetic route facilitated the preparation of a 4-nitro-1-(3′,4′,5′-trimethoxyphenyl) benzosuberene derivative and its corresponding 4-amino analogue in good yield. The 4-amino analogue was a strong inhibitor of tubulin polymerization (1.2 μM), demonstrated enhanced cytotoxicity against the human cancer cell lines examined (GI50 = 33 pM against SK-OV-3 ovarian cancer, for example), and exhibited a concentration dependent disruption of a pre-established capillary-like network of tubules formed from human umbilical vein endothelial cells.